Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means "inflammation of many muscles" (poly- + myos- + -itis).
This report contains market size and forecasts of Polymyositis Treatment in Global, including the following market information:
Global Polymyositis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Polymyositis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunosuppressant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polymyositis Treatment include Hospira, Inc., Antares Pharma, Inc., Medexus Pharma, Inc., Fresenius SE & Co. KGaA, Mylan N.V., Alcami Corporation, Teva Pharmaceuticals, Novartis AG and Genentech, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polymyositis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polymyositis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Polymyositis Treatment Market Segment Percentages, by Type, 2021 (%)
Immunosuppressant
Alkylating Agent
Immunoglobulin
Monoclonal Antibodies
Corticosteroids
Global Polymyositis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Polymyositis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Polymyositis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Polymyositis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polymyositis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Polymyositis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hospira, Inc.
Antares Pharma, Inc.
Medexus Pharma, Inc.
Fresenius SE & Co. KGaA
Mylan N.V.
Alcami Corporation
Teva Pharmaceuticals
Novartis AG
Genentech, Inc.